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Abstract  
Thousands of human proteins lack recognizable tertiary structure in most of their 
chains. Here we hypothesize that some use their structured N-terminal domains 
(SNTDs) to organise the remaining protein chain via intramolecular interactions, 
generating partially structured proteins. This model has several attractive features: as 
protein chains emerge, SNTDs form spontaneously and serve as nucleation points, 
creating more compact shapes. This reduces the risk of protein degradation or 
aggregation. Moreover, an interspersed pattern of SNTD-docked regions and free 
loops can coordinate assembly of sub-complexes in defined loop-sections and enables 
novel regulatory mechanisms, for example through posttranslational modifications of 
docked regions. 
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Introduction  
Proteins were for a long time thought to be mostly well-structured entities made up of 
one or several domains, which are assembled from spontaneously forming α-helices 
and/or β-strands, or are folded with the help of chaperones. However, over the last 
decades this simplistic view has been increasingly questioned. 
It is now clear that thousands of human proteins do not fit into simple categories of 
tertiary structural organisation, that is, in these cases, recognizable domains are 
completely or mostly missing. Such proteins have been called unstructured or 
‘intrinsically disordered’ (ID) [1]. 
 Approximately one third of human proteins lack recognizable secondary and tertiary 
structure in most of their protein chain and hence appear to fall into this category [2]. 
Some of them are being collected in the DisProt database [3], but most are excluded 
from detailed ultrastructural analyses, as they are often considered to be poor targets. 
Relatively little is known about their shapes, conformations and conformational 
changes presumably occurring. Nevertheless ID proteins have important functions in 
multi-protein complex assembly and cell signaling [4 - 7] and we need to learn much 
more about their molecular activities and mechanisms of action.  
Their abundance in cells is somewhat puzzling, for example raising questions 
regarding their escape from proteolytic degradation and lack of aggregate formation. 
It is well known that misfolded proteins are the cause of several major 
neurodegenerative disorders and other ‘protein deposit’ diseases [8 – 12]. In fact, 
almost all proteins contain segments that can in principle form amyloids [13]. Poorly 
folded proteins are also targets for degradation by the proteasome and other proteases 
[14 - 16]. However, structural disorder appears to serve only as a weak signal for 
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intracellular protein degradation and ID-proteins also do not appear to display an 
overall preference for chaperone binding in vivo [17], despite the prominent role that 
chaperones clearly play in supporting protein folding in general [18]. 
At least some, if not many, ID proteins may therefore adopt types of order that are not 
easily recognized by current secondary or tertiary structure prediction programmes. 
Examples of secondary structure elements that are usually not detected include the 
poly-proline type II (PPII)  [19 - 20] and 310 helices [21 - 22]. Despite their abundance 
in human proteins, new examples of these helices often only become apparent through 
focussed structural analyses of individual proteins. 
Beyond these often short, helical regions, it appears likely that several other molecular 
routes to generating order within unfolded protein chains exist, some of which may 
still remain to be studied in any detail. The first interesting mechanisms that allow the 
generation of defined structural states from a disordered conformation have recently 
emerged. For example, some ID proteins adopt specific, regionally restricted 
conformations upon binding their partner proteins. This can go as far as adopting 
multiple distinct conformations depending on which of several interactors is docking 
[23]. Another example are the recently proposed ‘disordered domains’, stretches 
longer than 20-30 amino acid residues, which are thought to present functional units 
for protein interactions [24]. 
We suggest here a further novel mechanism for rapidly establishing a certain degree 
of order within long ID protein chains. This N-terminal folding nucleation hypothesis 
provides an experimentally testable conceptual framework that has many attractive 
features in terms of explaining how some of the so-called ID proteins can effectively 
fulfil their functions in cells. 
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The emergence of the N-terminal folding nucleation (NFN) hypothesis 
Research in our and many other laboratories has increasingly focussed on the function 
of large multi-site docking (LMD) protein platforms like the Gab, p130Cas and IRS 
family proteins [5 – 6], which facilitate the assembly of large signal transduction 
protein complexes. Such multi-protein complexes are presumably required for the 
integration and processing of multiple inputs from different upstream signal 
transducers, with subsequent further propagation of several signals regulating cell 
survival, proliferation, cytoskeletal structures, migration and/or differentiation. In this 
context it was noticed that several families of LMD proteins display a similar 
structural composition, namely a well-structured N-terminal domain (SNTD), for 
example an SH3, PH or PTB domain, that is followed by a long and, according to 
secondary structure prediction programs, largely disordered protein chain (Figure 1). 
While this initially just seemed to be a curious feature without any obvious functional 
explanation, another unexpected and seemingly unrelated finding led to the 
emergence of a potential rationale for this peculiar LMD protein composition. It was 
found that in HEK293T cells, which display intrinsically high phosphatidylinositol-3 
(PI3) kinase activity, the full-length Gab1 protein is localised in the cytoplasm, 
instead of at the plasma membrane, as would be expected for cells with constitutively 
active PI3 kinase [25]. This was surprising because the Gab1 PH domain has been 
shown to preferentially bind PIP3 [26], the membrane-embedded product of PI3 
kinase.  
When following up this initial observation, it was found that in order to achieve 
membrane translocation of Gab1 via PIP3 binding of its PH domain, in these cells a 
further signal is needed. The kinase module Mek - Erk is required to phosphorylate a 
serine residue (Ser552) localized far away from the PH domain in the disordered tail 
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of the protein [25]. This clearly indicates that a distant part of the Gab1 tail region 
binds, either directly or indirectly, to the Gab1 PH domain, thereby blocking its PIP3 
binding pocket. Furthermore, this interaction occurs in a functionally regulated 
manner. To analyze the interaction between Gab1 PH and the Ser552 epitope further, 
we employed the peptide array overlay assay [27 – 29]. This is a frequently used 
method for the detection of protein domain interactions with short linear motifs that 
typically displays little non-specific binding. For this assay, the Gab1 protein is 
synthesized in the form of a series of overlapping peptides which are immobilized in 
spots on a cellulose carrier membrane. The affinity-purified Gab1 PH domain, 
expressed as a GST-fusion protein, is then used as probe to detect in vitro short linear 
Gab1 regions that may bind to the PH directly in vivo (Figure 2). From this, the 
Ser552-region emerged as a direct binding motif for the GST-PH probe. In addition, 
numerous other regions in the Gab1 protein also appeared as putative PH domain 
binders. None of these regions bound to GST alone. If these potential binding regions 
are also utilized in vivo, the Gab1 PH domain serves not only as a phospholipid-
binding module, but also as a nucleation core for the intramolecular binding, and 
hence compaction, of the supposedly disordered Gab1 tail region.  
 
This N-terminal folding nucleation (NFN) hypothesis has several attractive features: 
 
Firstly, it provides a simple explanation for how disordered proteins can escape 
protein aggregation or degradation by a co-translational folding mechanism that 
differs substantially from the classical formation of structured proteins. As the first 
terminal amino acids emerge from the ‘teflon-like’ ribosomal tunnel, secondary 
structural elements are spontaneously generated which rapidly assemble into a highly 
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stable SNTD. Once this is built, additional residues emerging from the ribosome can 
dock onto specific SNTD patches, thereby preventing the unstructured chain from 
engaging in nonspecific interactions and also preventing those patches on the SNTD 
from accepting the binding of external protein chains (Figure 3).  
Moreover, the intramolecular attachment of protein chain segments to the SNTD 
would seem to generate defined loops which may serve as regions for the assembly of 
distinct sub-complexes where protein compositions differ from those attached to other 
loop regions.  
In this context, it should be noted that the clustering of specific protein binding sites 
in LMD proteins of the Gab family was noticed years ago [30]. This clustering is 
presumed to contribute to the spatial organization of complex components. In Gab1, 
six CRKL SH2 domain candidate binding sites localize to a central region of ca. 170 
amino acids, while the other 525 amino acids lack even a single putative binding 
motif. Combined with the ability of the CRKL adaptor protein to dimerize and 
possibly tetramerize [31], highly ordered complexes of great stability could be formed 
in distinct regions of LMD proteins like Gab1.  
Clearly, these proposed concepts are for now speculative and in need of further 
experimental analyses. However, such concepts are urgently required to guide the 
design of new types of experiments that will help to define the mechanism of how 
distinct and very large signal transduction protein complexes (a.k.a. stimulus-specific 
‘signalosomes’) are rapidly assembled in response to diverse stimuli. The coordinated 
assembly of well-ordered signaling sub-complexes that can be differentially combined 
depending on the biological complex is intuitively appealing. It should allow the 
speedy generation of specific signals in discrete regions of an LMD protein and this 
must be very desirable for at least some signaling systems. In the case of Gab1/CRKL 
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complexes, which are prominently linked to cell shape change and motility signals 
through the activation of Rho family GTPases, it is easy to imagine multiple 
biological contexts where the ability to move swiftly would be advantageous. 
Another advantage of discrete regions docking onto the SNTD would be the 
generation of novel targets for signal regulation, which may, for example, contribute 
to the undoubtedly important robustness of cell signaling networks [32]. This is nicely 
exemplified by the Gab1 phosphorylation on Ser552. Only upon the generation of two 
signals, one through PI3 kinase activation and the other one by firing of the mitogenic 
kinases, will the important LMD protein Gab1 translocate to the membrane, where 
further phosphorylation leads to the assembly of a potent regulator complex of 
essential cell behaviours.  
 
Towards a solution  
To estimate how commonly NFN is utilized, we initially sought to define how many 
proteins in the human proteome display an SNTD in combination with a long 
disordered tail. For this, disordered regions and structural domains were predicted for 
all human proteins in the UniProt SwissProt database (www.ebi.ac.uk/uniprot/) using 
DisEMBL (http://dis.embl.de/) and SMART (http://smart.embl-heidelberg.de/), 
respectively. The two sets of predictions were compared using a custom perl script to 
identify proteins with a predicted domain or domains in the N-terminus (defined as 
the first 25% of the protein), no predicted domains in the C terminus (defined here as 
the remaining 75% of the protein) and predominantly disordered (>80%) in this C-
terminus. The initial hits were listed with their corresponding SMART and SwissProt 
data and then individually inspected to exclude, for example, transmembrane proteins. 
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This showed that, in addition to the protein families depicted in Figure 1, over 50 
further proteins display a similar structural organisation (for details see Supporting 
Figure 1). This number is probably an underestimate, since not all domains may yet 
be recognised by the SMART database and also because proteins with an SNTD and 
subsequent mostly unstructured tail, but with one or more additional domain(s) more 
C-terminally, were excluded from the initial search, even though they may use NFN 
for a part of their amino acid chain. Proteins with an SNTD and a relatively short ID 
tail were also not scored in this experiment. Of the more than 50 proteins that 
emerged from this analysis, a major portion is readily known or presumed to be 
involved in signaling processes.  
The NFN candidate proteins now need to be subjected to further biochemical, 
biological and biophysical analyses. Purification of these proteins from eukaryotic 
cells and analysis by gel filtration chromatography, analytical ultracentrifugation,  
mass spectrometry of intact proteins and small angle X-ray scattering (SAXS) should 
give some information about their shapes. NMR analyses of isolated SNTDs and full-
length proteins should identify residues in the SNTDs that contribute to 
intramolecular contacts with the ID chain. In some cases, even in vivo NMR, similar 
to a study conducted with bacterial FlgM may be possible [33]. 
Mutations of SNTD residues implicated from NMR experiments, and of key residues 
in the ID tails identified by peptide array overlay blots could then be analysed for 
functional defects or effects on protein turnover or aggregation in cells. In vivo studies 
with knock-in mutants can subsequently investigate the systemic consequences. It will 
also be interesting to determine whether some of the proteins utilising NFN are 
additionally stabilised in their compact shapes by complex formations with other 
proteins, which should co-purify in stoichiometric amounts.  
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Clearly nature has found multiple ingenious ways of folding emerging protein chains 
in highly complex organisms into functional units with great efficacy. As we learn 
more about these mechanisms, we will also begin to understand better the 
fundamental principles that govern the assembly and actions of complex signaling 
networks and their multi-protein hubs. 
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Figure legends 
 
 
Figure 1. Schematic structure of selected large multi-site docking (LMD) protein 
families involved in signaling. 
 
The Irs/Dok, Gab, p130Cas and Frs families of LMD proteins are crucial platforms 
for the assembly of elaborate multi-protein complexes (a.k.a. ‘signalosomes’) of a 
wide range of cell membrane receptors involved in regulating cell survival, growth, 
motility and/or differentiation. They all share a similar composition, that is a well- 
structured N-terminal domain (SNTD) followed by an apparently largely unstructured 
amino acid chain. In some cases, short secondary structure motifs like PPII helices, 
310 helices etc. have been found or are suspected. A human proteome-wide search 
subsequently revealed that a large number of proteins exist with a similar structural 
composition. For further details see Supporting Figure 1. 
 
 
Figure 2. Gab1 peptide array overlay assay identifies potential binding sites for 
the PH domain. 
 
For this assay, the full amino acid sequence of Gab1 from Mus musculus, also used in 
the study of Eulenfeld and Schaper [25], was chemically synthesized as an array of 
spots of overlapping peptides (Multipep synthesiser [Intavis], peptide lengths 23 
amino acids, sliding two residues further with each consecutive peptide), blocked with 
5% nonfat dry milk in TrisHCl buffer (pH7.5) with 0.1% Tween 20 added and probed 
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initially with 4 μg/ml GST, followed by incubation with anti-GST, HRP-coupled 
secondary antibody and ECL detection. No GST binding was detectable to any of the 
peptides (top panel). The same membrane was then re-probed with 1 μg/ml of 
affinity-purified GST-PH domain (bottom panel). The red box indicates the Ser552 
epitope previously implicated in regulating Gab1 PH domain binding by the work of 
Eulenfeld & Schaper. Similar results were also obtained when DTT was included in 
the assay to eliminate potential artefacts from non-specific interactions of Cys 
residues (data not shown). 
  
 
Figure 3. Graphical illustration of the N-terminal folding nucleation (NFN) 
hypothesis. 
 
The NFN hypothesis proposes that, as the nascent amino acid chain of an LMD 
protein emerges from the ribosome (depicted in grey), the SNTD is rapidly and 
spontaneously generated and this SNTD then serves as a nucleation core for 
additional and specific intramolecular protein chain contacts, which generate a more 
compact protein shape. The compaction avoids the presence of a long disordered 
amino acid chain, which may lead to protein proteolysis or aggregation. Instead, the 
interspersed pattern of docked regions and loops generates defined subsections in the 
protein that may serve as functional subunits. Protein modifications like 
phosphorylation in some of these defined regions may lead, for example, to the 
liberation of docked regions, allowing the SNTD to engage in novel types of 
interactions which could allow the anchorage of the LMD protein in specific 
subcellular locations. Other modifications may generate docking points for interaction 
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domains of signaling partner proteins, resulting in the rapid assembly of defined sub-
complexes on specific loops. Taken together, the features of LMD proteins emerging 
through NFN are expected to increase the ability of cells to respond rapidly and 
selectively to a diverse set of incoming stimuli. 
 
 
Supporting Figure 1. Human proteins identified as NFN candidates by 
bioinformatics analysis. 
 
Schematic representation of proteins identified by the prediction of disordered regions 
and structural domains for all human proteins in the UniProt SwissProt database 
(www.ebi.ac.uk/uniprot/) using DisEMBL (http://dis.embl.de/) and SMART 
(http://smart.embl-heidelberg.de/), respectively. The two sets of predictions were 
compared using a custom perl script to identify proteins with a predicted domain or 
domains in the N-terminus (defined as the first 25% of the protein), no predicted 
domains in the C terminus (defined here as the remaining 75% of the protein) and 
predominantly disordered (>80%) in this C-terminus.  Initial hits were listed with 
their corresponding SMART and SwissProt data and then individually inspected to 
exclude, for example, transmembrane proteins. Proteins shown here clearly represent 
an underestimate of actual candidates in the human proteome, since, for example, 
proteins with additional domains in the amino acid chain following the folded N-
terminus were excluded, even if several hundred disordered amino acids follow the N-
terminal domain. If multiple splice variants occur, only a single representative is 
shown for each protein. Proteins are alphabetically listed according to the gene names 
following the HGNC nomenclature (7-2010; http://www.genenames.org/), identifiers 
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below the names and SNTD designations are according to the SMART database. 
Protein domains and chain lengths are not drawn to scale. Values on the right side 
indicate the number of amino acids in each protein. Many of the NFN candidates 
depicted here are known or suspected to act in cell signaling. Please note that LMD 
proteins already shown in Figure 1 and again found in the bioinformatic analysis 
(FRS2, FRS3, GAB1, GAB2, GAB3, IRS1, IRS2, ) are not  shown again in this 
figure. 
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